What are the nephrotoxic agents in the patient's medication list?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nephrotoxic Agents in the Medication List

The only nephrotoxic agent in this medication list is aspirin (aspirin EC 81 mg PO QD), which can cause hemodynamic changes in the kidney by inhibiting prostaglandin synthesis. 1, 2

Analysis of Nephrotoxic Potential

Confirmed Nephrotoxic Agent:

  • Aspirin EC 81 mg PO QD: Even at low doses, aspirin belongs to the NSAID class, which can cause nephrotoxicity through several mechanisms:
    • Inhibition of prostaglandin synthesis leading to reduced renal blood flow 2
    • Potential for acute interstitial nephritis 2
    • Renovasoconstriction, particularly in patients with pre-existing kidney disease 1

Medications Without Significant Nephrotoxicity:

  1. Atorvastatin 10 mg PO QHS - Not nephrotoxic
  2. MiraLax 17 g PO PRN - Not nephrotoxic
  3. Depakote DR 125 mg PO BID - Not nephrotoxic
  4. Santyl 250 unit/g topical QD - Topical; minimal systemic absorption
  5. Cholecalciferol 75 mcg PO QD - Not nephrotoxic
  6. Renal-Vite 0.8 mg PO QD - Not nephrotoxic
  7. Mupirocin 2% topical QD - Topical; minimal systemic absorption
  8. Folic Acid 1 mg PO QD - Not nephrotoxic
  9. Metoprolol Tartrate 25 mg PO BID - Not nephrotoxic
  10. Levothyroxine 25 mcg PO QAM - Not nephrotoxic
  11. Docusate Sodium 100 mg PO BID - Not nephrotoxic
  12. Ferrous Sulfate 325 mg PO QD - Not nephrotoxic
  13. Acetaminophen 325 mg PO - Not directly nephrotoxic at therapeutic doses

Risk Assessment for Aspirin

While aspirin is nephrotoxic, the risk at the low dose of 81 mg daily is relatively low compared to higher doses or other NSAIDs. However, the nephrotoxic potential increases in certain situations:

  • In patients with pre-existing kidney disease (GFR <60 ml/min/1.73 m²) 1
  • During acute illness or volume depletion 2
  • When combined with other medications that affect renal hemodynamics 2
  • In elderly patients 3

Recommendations for Management

  1. Monitor renal function regularly with serum creatinine and BUN measurements, especially if the patient has risk factors for kidney disease 1

  2. Consider temporary discontinuation of aspirin during:

    • Acute illness with volume depletion
    • Planned IV contrast administration
    • Bowel preparation for colonoscopy
    • Prior to major surgery 1
  3. Avoid adding other nephrotoxic medications to the regimen, as each additional nephrotoxin increases the risk of acute kidney injury by approximately 53% 2

  4. Ensure adequate hydration, particularly important when the patient is also taking medications that may affect volume status 2

Conclusion

The medication list contains only one nephrotoxic agent - aspirin EC 81 mg PO QD. While the low dose presents minimal risk in patients with normal renal function, monitoring is still warranted, particularly in high-risk patients or during situations that may compromise renal function.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nephrotoxicity and Kidney Injury Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.